Figure 8 | Scientific Reports

Figure 8

From: Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive–compulsive disorder: a systematic review and meta-analysis of randomized clinical trials

Figure 8

Comparison of Y-BOCS score between patients with moderate to severe obsessive–compulsive disorder in experimental groups and control groups in week 4, 6, 8, and 10 in the obsession subgroup.

Back to article page